Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia 20 Precursor Cell Lymphoblastic Leukemia-Lymphoma 15 Lymphoma 11 Lymphoma, Non-Hodgkin 9 Lymphoma, Large B-Cell, Diffuse 9 Burkitt Lymphoma 9 Myelodysplastic Syndromes 8 Lymphoma, Follicular 8 Leukemia, Lymphocytic, Chronic, B-Cell 8 Multiple Myeloma 7 Leukemia, Myeloid, Chronic-Phase 7 Leukemia, Myeloid, Acute 7 Lymphoma, Mantle-Cell 6 Lymphoma, B-Cell, Marginal Zone 6 Hodgkin Disease 6 Blast Crisis 6 Recurrence 5 Neoplasms, Plasma Cell 5 Leukemia, Myeloid, Accelerated Phase 5 Graft vs Host Disease 5 Dendritic Cell Sarcoma, Interdigitating 5 Congenital Abnormalities 5 Myeloproliferative Disorders 4 Lymphoma, Large-Cell, Immunoblastic 4 Leukemia, Myelomonocytic, Juvenile 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Lymphoma, B-Cell 3 Leukemia, Myelomonocytic, Chronic 3 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 3 Hematologic Neoplasms 3

Interventions

tocilizumab 1 ceftolozane, tazobactam drug combination 1 Ribavirin 1 Nebulizers and Vaporizers 1 Methylprednisolone 1 Lidocaine 1 Immunoglobulin G 1 Gelsolin 1 Etanercept 1 Disulfides 1 Calcitriol 1 Blood Specimen Collection 1 Adrenal Cortex Hormones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Pneumonia × Methylprednisolone × Clear all

NCT00421174 2021-11-01

BMTCTN0403

National Heart, Lung, and Blood Institute (NHLBI)

Phase 3 Completed

37 enrolled 20 charts

Pneumonia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡